Citation Impact
Citing Papers
Deconstructing Cell-Free Extract Preparation for in Vitro Activation of Transcriptional Genetic Circuitry
2018
The Spring α-Helix Coordinates Multiple Modes of HCV (Hepatitis C Virus) NS3 Helicase Action
2016 StandoutNobel
Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition
2004 Standout
Cyclodextrins as pharmaceutical solubilizers
2007 Standout
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
The tor pathway: a target for cancer therapy
2004 Standout
Etodolac: Efficacy in osteoarthritis and effects on chondrocyte function
1990
Polyol pathway and diabetic peripheral neuropathy
2002
Hydrophobic mismatch drives self-organization of designer proteins into synthetic membranes
2024 StandoutNobel
Tumor necrosis factor-α, and interleukin-1β production by human fetal Kupffer cells
1991 StandoutNobel
Oral Anticoagulant Therapy
2012 Standout
2-Steps KOH activation of rice straw: An efficient method for preparing high-performance activated carbons
2009 Standout
Cellular Cholesterol Efflux Mediated by Cyclodextrins
1995 Standout
mTOR at the nexus of nutrition, growth, ageing and disease
2020 Standout
Targeting the phosphoinositide 3-kinase pathway in cancer
2009 Standout
mTOR Signaling in Growth, Metabolism, and Disease
2017 Standout
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
One Century of Aryne Chemistry
2003 Standout
The sided action of Na+ and of K+ on reconstituted shark (Na+ + K+)-ATPase engaged in Na+−Na+ exchange accompanied by ATP hydrolysis. I. The ATP activation curve
1987 StandoutNobel
Portal hypertensive bleeding in cirrhosis
2016 Standout
Ebola virus entry requires the cholesterol transporter Niemann–Pick C1
2011 StandoutNature
Is meiosis activating sterol (MAS) an obligatory mediator of meiotic resumption in mammals
2002
Recent clinical experience with etodolac in the treatment of osteoarthritis of the knee
1989
How were new medicines discovered?
2011 Standout
On-bead combinatorial techniques for the identification of selective aldose reductase inhibitors
2006
Effects of Paroxetine and Venlafaxine XR on Heart Rate Variability in Depression
2005
Role of Meiosis-Activating Sterols in Rat Oocyte Maturation: Effects of Specific Inhibitors and Changes in the Expression of Lanosterol 14α-Demethylase During the Preovulatory Period1
2001
Systematic Overview of Warfarin and Its Drug and Food Interactions
2005 Standout
Catalytic Asymmetric Hydroperoxidation of α,β‐Unsaturated Ketones: An Approach to Enantiopure Peroxyhemiketals, Epoxides, and Aldols
2008 StandoutNobel
Cyclodextrin-based pharmaceutics: past, present and future
2004 Standout
Antifungal agents: An overview. Part II
1994
Biosynthesis of glucosinolates – gene discovery and beyond
2010 Standout
Antioxidants, Oxidative Damage and Oxygen Deprivation Stress: a Review
2002 Standout
The Pharmacology and Management of the Vitamin K Antagonists
2004 Standout
The role of polyols in the pathophysiology of hypergalactosemia
1995
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Peroxy natural products
1992
A multicentre trial of the aldose-reductase inhibitor, tolrestat, in patients with symptomatic diabetic neuropathy
1990
The Effect of Parenterally Administered Cyclodextrins on Cholesterol Levels in the Rat
1991
A malachite green procedure for orthophosphate determination and its use in alkaline phosphatase-based enzyme immunoassay
1988 Standout
Impact of Depression and Antidepressant Treatment on Heart Rate Variability: A Review and Meta-Analysis
2010 Standout
A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability
1995 Standout
Determination of phosphate in serum and urine by a single step malachite-green method
1975
Azole fungicides affect mammalian steroidogenesis by inhibiting sterol 14 alpha-demethylase and aromatase.
2002 Standout
Specific tlc Determination of Trimethoprim and Sulfamethoxazole in Plasma
1974 StandoutNobel
Measuring Competence? Exploring Firm Effects in Pharmaceutical Research
1994 Standout
Molecular Recognition of Protein−Ligand Complexes: Applications to Drug Design
1997 Standout
Effects of NaCl, glucose, and aldose reductase inhibitors on cloning efficiency of renal medullary cells
1990
THE PROSTAGLANDINS
1967
Chemical analysis of the lung alveolar surfactant obtained by alveolar micropuncture
1973
Bochemical changes in layer and broiler chickens when fed on a high‐glucosinolate rapeseed meal
1983
Mixing-Tank Model for Predicting Dissolution Rate Control of Oral Absorption
1986
The effects of BM 15.766, an inhibitor of 7-dehydrocholesterol δ7-reductase∗, on cholesterol biosynthesis in primary rat hepatocytes
1986
Human liver mitochondrial monoamine oxidase. II. Determinants of substrate and inhibitor specificities
1969
Bis- and Trisindolylmethanes (BIMs and TIMs)
2009 Standout
Cholesterol biosynthesis in human fetal liver and adrenal
1971
Teratogen-Mediated Inhibition of Target Tissue Response to Shh Signaling
1998 StandoutScience
Synthesis of Cycloalkanoindoles by an Unusual DAST‐Triggered Rearrangement Reaction
2004
Abnormal cholesterol uptake, storage, and synthesis in the livers of 2-acetylaminofluorene-fed rats.
1973
Current and Emerging Azole Antifungal Agents
1999 Standout
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
Cyclodextrin Drug Carrier Systems
1998 Standout
Decomposition of benzenediazonium-3-carboxylate: transient 1,3-dehydrobenzene
1965
Short–Term Effects of Propranolol on Portal Venous Pressure
1986
Intestinal metabolism of tyramine by both forms of monoamine oxidase in the rat
1983 StandoutNobel
Cholesterol Synthesis Inhibitor U18666A and the Role of Sterol Metabolism and Trafficking in Numerous Pathophysiological Processes
2009
Differences in chemical composition and fibre digestion of rice straw with, and without, anhydrous ammonia from 53 rice varieties
1999
The Conversion of (--)-trans-2,3-Diphenylcyclopropane Carboxylic Acid to (+)-1,3-Diphenylallene
1963
Mechanisms of Diabetic Complications
2013 Standout
Diabetic Somatic Neuropathies
2004 Standout
Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution
1986 Standout
Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle.
1975 Standout
Na+Na+ exchange mediated by (Na+ + K+)-ATPase reconstituted into liposomes. Evaluation of pump stoichiometry and response to ATP and ADP
1985 StandoutNobel
Rates of various reactions catalyzed by ATP synthase as related to the mechanism of ATP synthesis.
1991 StandoutNobel
Functional Significance of Cell Volume Regulatory Mechanisms
1998 Standout
Microdetermination of Inorganic Phosphate, Phospholipids, and Total Phosphate in Biologic Materials
1967
Differential Regulation of Enolase during Anaerobiosis in Maize
1998
Mevalonate supplementation in pregnant rats suppresses the teratogenicity of mevinolinic acid, an inhibitor of 3‐hydroxy‐3‐methylglutaryl‐coenzyme a reductase
1983
The Relation Between Fertility and Prostaglandin Content of Seminal Fluid in Man
1970 StandoutNobel
Asymmetric ring opening of -dibromocyclopropanes leading to allenic hydrocarbons
1968 StandoutNobel
Polyol Accumulation in Galactosemic and Diabetic Rats: Control by an Aldose Reductase Inhibitor
1973 Science
De novo design of protein logic gates
2020 StandoutScienceNobel
Properties of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase Solubilized from Rat Liver and Hepatoma
1974 StandoutNobel
Works of M. Kraml being referenced
A semi-automated determination of serum triglycerides
1968
Cell-free protein synthesis from non-growing, stressed Escherichia coli
2017
Metabolic disposition and pharmacokinetics of the aldose reductase inhibitor tolrestat in rats, dogs, and monkeys.
1985
Pharmacokinetics of the aldose reductase inhibitor tolrestat: Studies in healthy young and elderly male and female subjects and in subjects with diabetes
1996
Tolrestat pharmacokinetics in rat peripheral nerve
1994
A High-Performance Liquid Chromatographic Method for the Simultaneous Determination of Venlafaxine and O-Desmethylvenlafaxine in Biological Fluids
1994
The pharmacokinetics of etodolac in serum and synovial fluid of patients with arthritis
1988
Disposition of a new tetrahydrocarbazole analgesic drug in laboratory animals and man
1989
Isolation of a Full-Length cDNA Encoding Cytosolic Enolase from Ricinus communis
1994
Gastrointestinal absorption of griseofulvin. II. Influence of particle size in man.
1962
Agents Affecting Lipid Metabolism. XVIII. A 7-Dehydrocholesterol Δ7-Reductase Inhibitor (AY-9944) as Tool in Studies of Δ7-Sterol Metabolism*
1966
The effect of some inhibitors of the postganglionic sympathetic mechanism on monoamine oxidase
1963
Comparative Bioavailability of Propranolol: Twice‐Daily Versus Four Times‐Daily Administration
1981
Fluorimetry of propranolol and its glucuronide: applicability, specificity, and limitations.
1978
Concomitant etodolac affects neither the unbound clearance nor the pharmacologie effect of warfarin
1994
Agents affecting lipid metabolism-I. on the inhibition of cholesterol biosynthesis by estrogens
1962
ADRENERGIC BETA RECEPTORS AND PLASMA FREE FATTY ACIDS
1966
Endogenous Formation of Δ5,7,24-Cholestatrien-3βol
1964
An automated determination of serum sulfonamides
1971
Effect of diurnal rhythm and food withdrawal on serum lipid levels in the rat
1972
A semi-automated determination of phospholipids
1966
Accumulation of 24-Dehydrocholesterol in Rats Treated with 22,25-Diazacholestanol
1963
A Novel Mode of Inhibition of Cholesterol Biosynthesis
1963
Tolrestat kinetics
1984
Inhibition of the conversion of 7-dehydrocholesterol to cholesterol by AY-9944
1964